Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design, 2012Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and wound healing, stable in human gastric juice, with no toxicity being reported. Recently, we claim that BPC 157 may be used as an antidote against NSAIDs. We focused on BPC 157
Sikirić, Predrag +18 more
openaire +3 more sources
Stable gastric pentadecapeptide BPC 157 and bupivacaine
European Journal of Pharmacology, 2016Bupivacaine toxicity following accidental overdose still lacks therapeutic solution. However, there are major arguments for testing BPC 157 against bupivacaine toxicity in vivo in rats, in particular, and then finally, in vitro. These are: the lack of any known BPC 157 toxicity, a lifesaving effect via the mitigation of arrhythmias in rats underwent ...
Živanović-Posilović, Gordana +12 more
openaire +3 more sources
Stable Gastric Pentadecapeptide BPC 157-NO-system Relation
Current Pharmaceutical Design, 2014We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close participation in Moncada's (maintained vascular integrity, platelets control) homeostatic healing response of NO-system to injury. Namely, BPC 157's particular healing effect also affects all events after vascular integrity loss (dependent on circumstances, it reduces ...
Sikirić, Predrag +18 more
openaire +4 more sources
Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula
European Journal of Pharmacology, 2016To establish the effects of BPC 157 on the healing of rat colovesical fistulas, Wistar Albino male rats were randomly assigned to different groups. BPC 157, a stable gastric pentadecapeptide, has been used in clinical applications-specifically, in ulcerative colitis-and was successful in treating both external and internal fistulas.
Grgić, Tihomir +10 more
openaire +2 more sources
Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats
Life Sciences, 2016Rectovaginal fistula is a devastating condition providing more than 99% of patients for surgical treatment. We hypothesized that rectovaginal fistula may be healed by therapy with stable gastric pentadecapeptide BPC 157, in consistence with its initial clinical application and effect on external fistulas.BPC 157 (10μg/kg or 10ng/kg) was given perorally,
Barić, Marko +10 more
openaire +3 more sources
The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice [PDF]
The stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV; mol. wt. 1419), which is at present in phase II clinical trials for the treatment of inflammatory bowel disease, has been shown to counteract healing impairment by systemic corticosteroids in burned mice, both in vivo and in vitro, in the absence of carrier or protease inhibitor.
Sven Seiwerth, Predrag Sikiric
exaly +4 more sources
Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation
European Journal of Pharmacology, 2019Recently, stable gastric pentadecapeptide BPC 157 reversed the high MDA- and NO-tissue values to the healthy levels. Thereby, BPC 157 therapy cured rats with bile duct ligation (BDL) (sacrifice at 2, 4, 6, 8 week). BPC 157-medication (10 μg/kg, 10 ng/kg) was continuously in drinking water (0.16 μg/ml, 0.16 ng/ml, 12 ml/rat/day) since awakening from ...
Zenko Sever, Anita +13 more
openaire +4 more sources
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats
Current NeuropharmacologyThis review explores the therapeutic potential of the stable gastric pentadecapeptide BPC 157 in addressing electrolyte imbalances, specifically hyperkalemia, hypokalemia, hypermagnesemia, and hyperlithiemia.
Marija Medvidovic, Grubisic +21 more
openaire +2 more sources
Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
Current pharmaceutical design, 2013Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and wound healing, stable in human gastric juice, with no toxicity being reported. Recently, we claim that BPC 157 may be used as an antidote against NSAIDs. We focused on BPC 157
Šebečić, Božidar +15 more
openaire +1 more source
Stable gastric pentadecapeptide BPC-157 heals transected muscle in rat.
Digestive diseases and sciences, 2003Stable gastric pentadecapeptide BPC-157 heals transected muscle in rat.
Starešinić, Mario +10 more
openaire +2 more sources

